Due to a high upregulation of CD44 in glioblastoma patients compared to HV, we hypothesized that the immunoprecipitation of EVs with CD44 would lead to an enrichment of glioblastoma-specific EVs. The gene discussed is CD44; the disease is glioblastoma.